Question 1

What is the ESG rating for PFE?

Accepted Answer

Pfizer Inc. has the following ESG ratings: MSCI ESG Rating: a, Sustainalytics ESG Risk: 59, ESG Enterprise Score: BBB.

Question 2

What are the main strengths of investing in PFE?

Accepted Answer

The main strengths of investing in Pfizer Inc. include: Global pharmaceutical leader with 100+ pipeline programs and $25B+ peak sales potential, Strong ESG leadership including health equity initiatives and science-based carbon targets, Operational revenue growth of 11% excluding COVID products with diversified therapeutic portfolio.

Question 3

What are the potential drawbacks of investing in PFE?

Accepted Answer

Potential drawbacks of investing in Pfizer Inc. include: Patent cliff risks affecting key revenue-generating drugs and biosimilar competition, Regulatory approval uncertainties and clinical trial success rates impacting pipeline value, Healthcare pricing pressures and government cost containment measures globally.

Question 4

What are the key financial metrics for PFE?

Accepted Answer

Key financial metrics for Pfizer Inc. include: Market Cap: $3.98 billion, Current Price: $117.97, Dividend Yield: 7.08%.

Pfizer Inc.

Detailed View

PFE

ESG Ratings